Peripheral neuropathy - Treatment with a drug from list 1 Factor
Last reviewed for CCPS 15 March 2006.
Investigative Documents
Medical Report - Drug Causing Peripheral Neuropathy - Peripheral neuropathy [MR9293]
Preliminary questions [32926]
there is some evidence that being treated with a drug from Specified List 1 may be a factor in the development of the condition under consideration.32937 the veteran was being treated with a drug from Specified List 1 for treatment of an illness or injury which is identifiable.
the identified illness or injury, for which the veteran was being treated with a drug from Specified List 1, is a condition for which the drug cannot be ceased or substituted. for the identified illness or injury, the veteran was being treated with a drug from Specified List 1, which could not be ceased or substituted, at the time of the clinical onset of the condition under consideration.32938 — the veteran has established the causal connection between being treated with a drug from Specified List 1 and VEA service for the clinical onset of peripheral neuropathy.
32939 — the veteran has established the causal connection between being treated with a drug from Specified List 1 and operational service for the clinical onset of peripheral neuropathy.
or
32940 — the veteran has established the causal connection between being treated with a drug from Specified List 1 and eligible service for the clinical onset of peripheral neuropathy.
Clinical onset and operational service [32939]
32935 — the identified illness or injury, for which the veteran was being treated with a drug from Specified List 1, is causally related to operational service.
Clinical onset and eligible service [32940]
the identified illness or injury was treated with a drug from Specified List 1 which is available for eligible service cases.32936 — the identified illness or injury, for which the veteran was being treated with a drug from Specified List 1, is causally related to eligible service.